VBL Therapeutics

2 stories about VBL Therapeutics
דרור חרץ מנכ"ל VBL

VBL Therapeutics Aims to Raise $18.75 Million in Public Offering

20.11.17|Lilach Baumer
The cancer treatment company announced an offering of 2.5 million shares last week
VBL Therapeutics

Japanese NanoCarrier Partners with Cancer Treatment Company VBL Therapeutics

07.11.17|Dror Reich
The companies signed an exclusive licensing agreement in Japan for VBL's anti-cancer drug